Compare MFA & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MFA | QDEL |
|---|---|---|
| Founded | 1997 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | N/A | 2022 |
| Metric | MFA | QDEL |
|---|---|---|
| Price | $9.95 | $10.81 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | $11.05 | ★ $28.25 |
| AVG Volume (30 Days) | 1.4M | ★ 2.9M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 14.16% | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | N/A | $3.51 |
| Revenue Next Year | $10.02 | $3.86 |
| P/E Ratio | $7.75 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.78 | $10.21 |
| 52 Week High | $10.57 | $35.58 |
| Indicator | MFA | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 48.35 | 34.51 |
| Support Level | $9.75 | N/A |
| Resistance Level | $10.26 | $17.78 |
| Average True Range (ATR) | 0.21 | 0.93 |
| MACD | -0.05 | 0.07 |
| Stochastic Oscillator | 44.55 | 18.14 |
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.